(Press-News.org) Children with asthma who use at-home monitoring are around half as likely to visit the emergency department or be hospitalised, compared to those who only receive care from their medical team, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1]. Remote monitoring also helped keep children’s symptoms under control.
At-home monitoring involved children and their families using an app approximately once a month to answer questions about asthma symptoms or track their lung function. The app also contains asthma action and treatment plans, and information on prescribed medications and instructions on how to use them. At-home monitoring is used to reduce in-person outpatient visits when children have stable asthma symptoms.
The research was presented by Dr Martinus Oppelaar from Amalia Children’s Hospital, Radboud University Center, Nijmegen, the Netherlands. He told the Congress: “Our team has previously run a successful clinical trial where we showed that remote asthma monitoring can replace 50% of standard outpatient appointments. However, routine care in the real world is more complex and messier than a highly controlled research setting.
“In the following years, we’ve been able to scale up our remote monitoring platform for large-scale use in routine care. This put us in the unique position to study how the research translates to these complex and messy routine care settings. This is a very important next step in the digital transition of health systems.”
The new research included data on 2,528 children with asthma, aged between six and 18, being cared for at six Dutch hospitals between 2017 and 2023. Of these, 1,374 children used remote monitoring at least some of the time and 2,236 children were not using remote monitoring some or all of the time. Some of the children are included in both groups as they spend some time not using remote monitoring, then switched to remote monitoring during the study.
Children were followed for two to three years on average, and, in that time, researchers recorded the number of visits children made to the hospital emergency department and whether the children were hospitalised.
The research showed that remote monitoring reduced the risk of an emergency hospital visit by around 49% and the risk of being hospitalised by around 57%. The researchers calculated that one hospitalisation could be prevented for every 39 children using remote monitoring.
The remote monitoring system Luchtbrug [2], created by researchers from Radboud University Medical Center, also collects data on whether children’s asthma symptoms are under control or not. Overall, the proportion of children with well-controlled asthma increased from 77% to 86% after they started using the system.
Dr Oppelaar said: “By studying remote monitoring in the real world, we have been able to show that there are clear benefits in terms of preventing the need for hospital care for children with asthma. We see an immediate drop in visits to the emergency room and hospitalisations, and a longer-term reduction in symptoms and children needing in-person outpatient care.
“Remote monitoring is not a new drug; it won’t make your disease disappear. It can however help children and their families manage their asthma better. Managing a chronic disease can be tough, especially for children, remote monitoring can make it a little bit easier. This then leads to better outcomes and lasting self-management skills.
“Crucially, the monitoring system also alerts the hospital if there are signs of children’s symptoms getting worse. This means doctors and nurses can make contact and change children’s treatment when needed.”
Dr Louise Fleming, from the European Respiratory Society’s expert group on paediatric asthma and allergy, and professor of practice in paediatric respiratory medicine at Imperial College London, UK, who was not involved in the research said: “Childhood asthma is extremely common, affecting around one out of every ten children in Europe. When asthma is well-controlled, children can enjoy and normal life. However, if symptoms flare up, children can become seriously ill and may need emergency treatment in hospital, and this can be horrible for children and their families.
“We already have good evidence from clinical trials that at-home monitoring can keep children with asthma well. This new study builds on that research by looking at how at-home monitoring works for children and their families in normal life. The results show that with monitoring we can keep more children well and out of hospital.
“If we can implement more remote services like this one, it will help us to offer the best healthcare services to our patients without increasing costs.”
END
Children with asthma who use at-home monitoring are half as likely to need hospital care
2025-09-28
ELSE PRESS RELEASES FROM THIS DATE:
Combination inhaler reduces asthma attacks in children by almost half
2025-09-28
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.
In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, the current standard for asthma symptom relief in children, with no additional safety concerns.
The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – ...
Low-cost drug shows promise for patients with life threating respiratory infections
2025-09-28
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National University (ANU) in collaboration with King’s College London.
The study analysed data from almost 500 patients hospitalised with COVID-19 across six countries. Patients who inhaled heparin were half as likely to require ventilation and had a significantly lower risk of dying compared with those receiving standard care.
Heparin, a drug traditionally injected to treat blood clots, was tested in this study in an inhaled form, targeting the lungs directly. As well as acting as an anticoagulant, ...
Emergency medicine workers report job satisfaction, though burnout and staff retention remain major problems
2025-09-27
Vienna, Austria: One of the largest international surveys into job satisfaction among emergency department workers has revealed that while the majority found their work satisfying and rewarding, there are still many areas where improvements are needed, according to research presented at the European Emergency Medicine Congress today (Sunday) [1]. The paper, “Global Job Satisfaction Among Emergency Medicine Professionals: Results from the 2025 Emergency Medicine Day Survey”, is published today in the European Journal ...
Eating fruit may reduce the effects of air pollution on lung function
2025-09-27
Eating fruit may reduce the effects of air pollution on lung function
Eating fruit may reduce the effects of air pollution on lung function, according to research presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1].
The study was presented by Pimpika Kaewsri, a PhD student from the Centre for Environmental Health and Sustainability at the University of Leicester, UK.
She explains: “Over 90% of the global population is exposed to air pollution levels that exceed WHO guidelines, and ample ...
Pulp mill waste becomes green solution to remove toxic dyes
2025-09-27
Dyes like Congo red and methyl orange create brightly hued shirts, sweaters and dresses. But these commonly used azo dyes can be toxic, carcinogenic and are hard to remove from wastewater.
David Chem, a University of Arkansas chemical engineering Ph.D. candidate, developed an environmentally friendly solution to remove these dyes using a common byproduct of the pulp and paper industry.
Azo dyes are used in 60-70% of commercial textile production. The dyes dissolve easily in water and resist biodegradation, which makes them an environmental hazard. ...
Sustainable generative AI: UCLA develops novel light-based system
2025-09-26
Today’s popular chatbots and image generators have a severe downside for the environment.
These examples of generative artificial intelligence leave a substantial carbon footprint due to outsized energy demands. At the same time, the large amount of water used to cool the equipment behind generative AI depletes a finite resource that humans, other animals and plants need in order to survive. Additionally, running such models requires massive computational infrastructure, raising concerns about their long-term sustainability.
Now, researchers at the UCLA Samueli School of ...
University of Phoenix publishes new white paper on microservice using achieved skills to build confidence between students and employers
2025-09-26
University of Phoenix today announced the publication of a new white paper, “Leveraging Achieved Skills to Improve Confidence Between Students and Employers,” authored by Francisco Contreras and Brandon Edwards of the University’s careers product team. The paper outlines how a record of a learners’ achievements and attested skills can help students and employers speak a common language of skills, and help working adult learners see where they may qualify—and where they are close—before they apply.
“When learners can see verified, granular skills mapped from their coursework and experience—and employers can see the same—confidence ...
ASTRO: Targeted radioactive therapy for recurrent prostate cancer, new SBRT approaches, 5DCT-guided imaging advances and more
2025-09-26
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on targeted radioactive therapy for recurrent prostate cancer, new approaches to stereotactic body radiation for prostate and head and neck cancers, advances in MRI- and 5DCT-guided imaging for more precise treatments, and innovations in patient-focused cancer education.
At this year’s scientific meeting, Dr. Amar Kishan, executive vice chair of radiation oncology at UCLA and co-director of ...
University of Cincinnati Cancer Center members present radiation oncology research at national conference
2025-09-26
University of Cincinnati Cancer Center researchers will present abstracts at the American Society for Radiation Oncology (ASTRO) annual meeting Sept. 27 through Oct. 1 in San Francisco.
Study evaluates safety, efficacy of head and neck proton re-irradiation
Patients with head and neck malignancies face a high risk of disease recurrence and the development of secondary primary cancers. While surgery is the preferred treatment in these cases, it is not always feasible based on tumor location or prior treatments.
An additional course of proton radiation therapy called re-irradiation can be ...
ASTRO 2025: At 10 years, SBRT comparable to surgery for early-stage lung cancer
2025-09-26
Study is the first to compare 10-year outcomes from surgery and a specific kind of radiation therapy known as SBRT (also called SABR) in non-small cell lung cancer
Survival outcomes were similar, but the SBRT group had fewer side effects and potentially less financial burden
Study further confirms radiation as an alternative for these patients, even in cases where the cancer is operable
SAN FRANCISCO, Sept. 26, 2025 ― Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology ...